After the Centers for Medicare & Medicaid Services (CMS) released a final rule that poses sizable risk to its Medicare Advantage business, Humana Inc. (NYSE: HUM) leaders insisted panic was not necessary. All the while, the company continued to tout its home health growth.
Read the full article: Amid Higher MA Scrutiny, Humana Remains Focused on Home Health Growth //
Source: https://homehealthcarenews.com/2023/02/amid-higher-ma-scrutiny-humana-remains-focused-on-home-health-growth